The complex diagnosis of primary heart involvement in systemic sclerosis: red flags to drive the choice of cardiac magnetic resonance Get access

• Abstracts

Graphical Abstract Get access

The incidence of anti-HMGCR immune-mediated necrotising myopathy: an Australian and UK retrospective multi-site cohort study

• Abstract
• Supplementary data

Intensive therapeutic plasma exchange in life-threatening ANCA-associated vasculitis Get access

Epidemiology of major and minor relapses in giant cell arteritis according to EULAR definitions: insights from the ARTESER registry Get access

• Abstract
• Supplementary data

Physical activity in relation to the risk of systemic lupus erythematosus: a prospective study including 401 745 individuals Get access

• Abstract
• Supplementary data

Kaplan–Meier survival curves of patients with systemic lupus erythematosus ... Get access

Endothelial cell dysfunction in rheumatoid arthritis: biomarkers IL-8, E-selectin, VCAM-1 and MCP-1 correlated with PET/CT Get access

• Abstract
• Supplementary data

Differential impact of immune-mediated inflammatory diseases before versus after cancer on patient survival: a nationwide cohort study Get access

• Abstract
• Supplementary data

Flow diagram of the UK Biobank participants included in the study Flow d... Get access

Subgroup analyses of the association between physical activity groups and i... Get access

Comment on: Predictors of lack of response to methotrexate in juvenile idiopathic arthritis associated uveitis. Reply Get access

• Extract

Trends in remission rates for rheumatoid arthritis in England and Wales: a population-level cohort study

• Abstract
• Supplementary data

Long-term effectiveness and safety of baricitinib treatment on refractory or severe juvenile dermatomyositis Get access

• Abstract
• Supplementary data

E059 Inpatient gout referrals - a missed opportunity or successful intervention?

• Abstract

E056 Prevalence and risk factors of low bone mineral density in spondyloarthritis

• Abstract

P179 Bimekizumab demonstrates sustained improvement in quality of life up to week 104 in patients across the full spectrum of axial spondyloarthritis: results from phase 3 studies

• Abstract

P134 Normal creatine kinase in inflammatory myositis

• Abstract

P132 The preferential Pde4b inhibitor nerandomilast (BI 1015550) exhibits antifibrotic and anti-inflammatory effects in human in vitro SSc models

• Abstract

P093 A CD25 enhancer variant linked to juvenile idiopathic arthritis skews CD4⁺ T-Cell responses towards a proinflammatory profile, modifiable by low-dose IL-2

• Abstract